Bionano transform the way the world sees the genome through Optical Genome Mapping solutions, diagnostic services, and software. Bionano Saphyr® system offers an extremely long-read technology, providing unmatched sensitivity to detect any type of structural variation (SV) and copy number variation (CNV), unbiased and genome wide, at low cost.
Different from sequencing and by leveraging direct visualization of whole-genome DNA molecules, Bionano workflow can resolve complex repetitive regions, and Bionano’s high coverage depth can identify low allele fraction event.
Vizgen is developing the next generation of genomic profiling tools that enable researchers to gain new insight into the biological systems that underlie human health and disease with spatial context. The company's MERSCOPE platform enables massively multiplexed, genome-scale nucleic acid imaging with high accuracy and unrivalled detection efficiency at subcellular resolution. MERSCOPE provides transformative insight into a wide range of tissue-scale basic research and translational medicine. For more information, go to www.vizgen.com.
Arima Genomics is a biotechnology company that advances the life sciences through the power of 3D genomes. We develop innovative solutions that drive discovery in genomics and improve human health. Our advanced Hi-C technology enables a range of products and applications by providing unparalleled access to the sequence and structure of any genome.
PreOmics – Setting the Standard for Protein Analysis
PreOmics empowers our clients in life sciences to establish biological knowledge through efficient, reliable solutions and workflows that set the standard for protein analysis.
We envisage a future with revolutionary proteomic discovery processes open for everyone.
At Biognosys, we believe that deep proteome insights hold the key to breakthrough discoveries that transform science for better lives. We make the proteome actionable to empower research, drug development, and clinical decision-making with our versatile portfolio of mass spectrometry-based proteomics research services, software, and kits. These solutions provide a multi-dimensional view of protein expression, function, and structure in all biological species and sample types.
Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications, and expertise, enabling customers to gain the insights they seek. Agilent is providing the entire workflow of target enrichment for different NGS applications such as cancer, infectious and rare diseases. including sample quality control (QC), next-generation sequencing (NGS) library prep and target enrichment, microarrays, CRISPR, PCR/qPCR, bioreagents, and data analysis solutions from interpretation reporting. Furthermore, with the extensive cancer diagnostic and pathology know-how of Agilent Dako, built on more than 50 years of experience, our business of antibodies & assay solutions has established lasting partnerships worldwide with partnering companies, ranging from large multinationals to smaller manufacturers and commercial laboratories specializing in the fields of in vitro diagnostics, biotechnology and pharmaceuticals. Besides the development of companion diagnostic for novel personalized therapy in cancer treatment, collaboration partners also benefit from the high level of familiarity of the Agilent Pathology-portfolio in routine diagnostic.
Quantabio is a leading provider of advanced DNA and RNA amplification reagents for the most demanding molecular testing applications in applied, translational, and life science research. Our team leverages decades of experience in developing pioneering amplification technologies to deliver cutting-edge products to researchers focused on critical cloning, PCR, qPCR, and Next-Generation Sequencing (NGS) applications.
Based in Beverly, Massachusetts, Quantabio offers a growing portfolio of products through its international sales operations, as well as a global network of distributors and commercial service providers.
